A. Christopher Toth's most recent trade in Baxter International Inc. was a trade of 25,372 Common Stock, $1 par value done at an average price of $32.6 . Disclosure was reported to the exchange on Jan. 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Baxter International | Christopher A. Toth | EVP, Group Pres, Kidney Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.56 per share. | 31 Jan 2025 | 25,372 | 105,186 (0%) | 0% | 32.6 | 826,112 | Common Stock, $1 par value |
| Baxter International | Christopher A. Toth | EVP,Group Pres, Kidney Care | 31 Dec 2024 | 32,610 | 183,876 (0%) | 0% | 29.2 | 950,908 | Common Stock, $1 par value | |
| Baxter International | Christopher A. Toth | EVP,Group Pres, Kidney Care | 03 Jun 2024 | 15,202 | 213,282 (0%) | 0% | 34.1 | 518,084 | Common Stock, $1 par value | |
| Baxter International | Christopher A. Toth | EVP,Group Pres, Kidney Care | 06 Mar 2024 | 119,076 | 227,761 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Baxter International | A. Christopher Toth | EVP, Group Pres, Kidney Care | 01 Jun 2023 | 106,358 | 106,358 (0%) | 0% | 0 | Common Stock, $1 par value |